Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study.
Terzolo M, Fassnacht M, Perotti P, Libé R, Kastelan D, Lacroix A, Arlt W, Haak HR, Loli P, Decoudier B, Lasolle H, Quinkler M, Haissaguerre M, Chabre O, Caron P, Stigliano A, Giordano R, Zatelli MC, Bancos I, Fragoso MCBV, Canu L, Luconi M, Puglisi S, Basile V, Reimondo G, Kroiss M, Megerle F, Hahner S, Kimpel O, Dusek T, Nölting S, Bourdeau I, Chortis V, Ettaieb MH, Cosentini D, Grisanti S, Baudin E, Berchialla P, Bovis F, Sormani MP, Bruzzi P, Beuschlein F, Bertherat J, Berruti A. Terzolo M, et al. Among authors: cosentini d. Lancet Diabetes Endocrinol. 2023 Oct;11(10):720-730. doi: 10.1016/S2213-8587(23)00193-6. Epub 2023 Aug 21. Lancet Diabetes Endocrinol. 2023. PMID: 37619579 Free PMC article. Clinical Trial.
In vitro antitumor activity of progesterone in human adrenocortical carcinoma.
Fragni M, Fiorentini C, Rossini E, Fisogni S, Vezzoli S, Bonini SA, Dalmiglio C, Grisanti S, Tiberio GAM, Claps M, Cosentini D, Salvi V, Bosisio D, Terzolo M, Missale C, Facchetti F, Memo M, Berruti A, Sigala S. Fragni M, et al. Among authors: cosentini d. Endocrine. 2019 Mar;63(3):592-601. doi: 10.1007/s12020-018-1795-x. Epub 2018 Oct 26. Endocrine. 2019. PMID: 30367443 Free article.
Immunotherapy failure in adrenocortical cancer: where next?
Cosentini D, Grisanti S, Dalla Volta A, Laganà M, Fiorentini C, Perotti P, Sigala S, Berruti A. Cosentini D, et al. Endocr Connect. 2018 Dec;7(12):E5-E8. doi: 10.1530/EC-18-0398. Endocr Connect. 2018. PMID: 30400026 Free PMC article.
Antineoplastic activity of artemisinin in adrenocortical carcinoma.
Lorini L, Grisanti S, Ambrosini R, Cosentini D, Laganà M, Grazioli L, Tiberio GAM, Sigala S, Berruti A. Lorini L, et al. Among authors: cosentini d. Endocrine. 2019 Nov;66(2):425-427. doi: 10.1007/s12020-019-02077-7. Epub 2019 Sep 6. Endocrine. 2019. PMID: 31493273 No abstract available.
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆.
Fragni M, Palma Lopez LP, Rossini E, Abate A, Cosentini D, Salvi V, Vezzoli S, Poliani PL, Bosisio D, Hantel C, Tiberio GAM, Grisanti S, Memo M, Terzolo M, Berruti A, Sigala S. Fragni M, et al. Among authors: cosentini d. Mol Cell Endocrinol. 2019 Dec 1;498:110585. doi: 10.1016/j.mce.2019.110585. Epub 2019 Sep 16. Mol Cell Endocrinol. 2019. PMID: 31536779
Treatment With 90Y/177Lu-DOTATOC in Patients With Metastatic Adrenocortical Carcinoma Expressing Somatostatin Receptors.
Grisanti S, Filice A, Basile V, Cosentini D, Rapa I, Albano D, Morandi A, Laganà M, Dalla Volta A, Bertagna F, Tiberio GMA, Volante M, Terzolo M, Versari A, Berruti A. Grisanti S, et al. Among authors: cosentini d. J Clin Endocrinol Metab. 2020 Mar 1;105(3):dgz091. doi: 10.1210/clinem/dgz091. J Clin Endocrinol Metab. 2020. PMID: 31633759 Free article.
70 results